Receives one observation under Form 483 for its API Facility located at Karkhadi
Alembic Pharmaceuticals announced that the United States Food and Drug Administration (US FDA) has conducted an inspection at Alembic Pharmaceuticals API Facility located at Karkhadi from 14 May, 2018 to 18 May, 2018. This was a scheduled inspection and at the end of the inspection, the US FDA issued a Form 483 with one observation.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
